Detect
Classification
Private
About
About
Detect, Inc. is a biotechnology company that specializes in developing and providing rapid, accurate, and affordable diagnostic testing solutions. The company focuses on leveraging cutting-edge technology to enhance early detection and monitoring of diseases, aiming to improve healthcare outcomes and accessibility. Product/Service Line Breakdown: 1. Rapid Diagnostic Tests: Highly sensitive and specific tests designed for quick detection of various diseases, providing results within minutes. 2. At-Home Testing Kits: User-friendly kits that enable individuals to conduct diagnostic tests from the comfort of their homes, ensuring privacy and convenience. 3. Clinical Diagnostic Solutions: Advanced diagnostic tools and platforms tailored for healthcare providers to enhance diagnostic accuracy and patient care in clinical settings. 4. Data Analytics and Reporting: Comprehensive software solutions that analyze test results and provide actionable insights for better disease management and monitoring. 5. Research and Development Services: Collaborative R&D initiatives aimed at developing new diagnostic technologies and improving existing ones to meet emerging healthcare challenges.
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
Keywords
Keywords
Classified
Private